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Scientific research is difficult and often depressingly Sisyphean. The pleasure we get from the rare decisive result is often obliterated by the knowledge that we have 
to write up the paper to get any credit for it. We start 
writing and then, after many revisions, submit the 
paper. Is there anything more ego-degrading than 
having the paper rejected? Why can’t they see that, 
unlike others (that is, probably, the reviewers), we 
are attacking diﬃcult problems, while those who go 
after low-hanging fruit seem to have their papers sail 
through? Why do they focus on trivial methodo-
logical issues or irrelevant controls, leaving the big 
ideas we propose to languish without any comment? 
To add insult to injury, all we get is a form letter 
from the editor saying that the reviewers did not 
like the paper — as if the editor is a secretary who 
pushes papers from one reviewer to another rather 
than somebody who is supposed to think independ-
ently. Of course, had we belonged to the right club, 
none of this would have happened. If you haven’t 
had these thoughts at one time or another, you must 
be living on a diﬀerent planet. All of us (editors are 
also authors) have suﬀered through these feelings. 
Not being an expert on the psychology of paranoia, I 
naively thought that it was rare. But, upon a cursory 
look in the literature, I found that ideas of persecu-
tion (in the absence of psychiatric illness) are very 
frequent; one study of college students showed that 
almost half of them have these symptoms.1
Aware of such thoughts, we, the editors, encour-
age authors to suggest reviewers to use in the peer 
review of their papers in the hope that they will 
choose sympathetic referees. An editor who looks 
at this ‘preferred’ list of reviewers quickly checks 
PubMed to see whether they are former coauthors 
and, more importantly, whether they actually know 
something about the ﬁeld; after all, paranoia is not 
restricted to authors—we have it too! Like most 
other journals, Kidney International allows authors 
to exclude reviewers. The problem, however, is that 
too often those excluded are the most appropriate 
reviewers. There have been instances when one 
author excluded so many reviewers that the whole 
subﬁeld was excluded. Regardless, we often accom-
modate these wishes; however, I hope it is under-
stood that exclusion of reviewers is interpreted by 
us as a suggestion, not a mandate.
From a sociological point of view, paranoid 
ideation and ideas of persecution are often seen in 
those without power: immigrants, the marginal-
ized, the weak, and those who feel that their fate is 
determined by others, and to malignant others at 
that.2 It is a bit of exaggeration to say that authors 
belong in this category of powerless people; yet after 
submission of the manuscript there is no doubt that 
its fate has been handed over to others. Given the 
emphasis on publication in our academic reward 
system, it is not surprising that allowing others to 
determine the fate of something this important can 
generate feelings of persecution. Surprisingly, the 
demand to exclude ‘hostile’ reviewers is not as com-
mon as one would think.
I confess that I have often used excluded review-
ers, and my impression was that their reviews 
were no harsher than those of preferred, presum-
ably friendly reviewers. Over the past year or so, 
I conducted a mini-study whose results might be 
of interest. Those of you with an epidemiological 
bent should, however, refrain from calculating the 
power of my conclusions, since this analysis has 
all the hallmarks of papers we usually reject: it is 
retrospective, the controls are likely to be diﬀerent 
from the experimental group, too few papers were 
examined, and so on. Further, given that review-
ers were excluded, the editors were conscious of 
the fact that the authors felt they might be in con-
ﬂict. Hence, we looked at these reviews diﬀerently. 
Despite all these caveats, I feel that this analysis 
resembles the best kind of case report in being 
anecdotal but telling in its content, and showing 
that, if there is an eﬀect, it is too small to warrant a 
more comprehensive study.
Only about 8% of authors in the past year excluded 
reviewers. Does this suggest that we have become 
wiser than the average college student? The study 
by Ellett et al.1 suggested that many college students 
who exhibited paranoid ideas had “poor self-esteem.” 
This is probably why our paranoia is so much less 
frequent than theirs; nobody can accuse professors 
in medical schools (the majority of our authors) of 
having low self-esteem. I read the 24 papers of which 
we had received reviews from referees thought to 
be antagonistic. For each paper we had also asked 
at least one and sometimes more than one ref-
eree who was listed by the author as ‘preferred.’ 
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Of these 24 papers we had already accepted eight, 
and one was still awaiting the receipt of minor 
revisions before it was ﬁnally accepted. Hence, we 
accepted 38% (9/24) of the papers. We rejected eight 
on the basis of the recommendation of both review-
ers. In addition, three were rejected because the 
preferred, but not the excluded, reviewers recom-
mended that outcome. Another four were rejected 
because the excluded, but not the preferred, review-
ers recommended so. These numbers are not very 
diﬀerent from our general statistics on editorial deci-
sions for the past year. We reject 60% of submissions 
without review. Of the reviewed papers (that is, the 
comparison group), we accept 45%, compared with 
the 38% of those with excluded reviewers.
Although this ‘outcome analysis’ demonstrates 
that there is no reason for paranoia, it is worth-
while to examine whether the tone of the reviews 
by the enemies diﬀered from that of the reviews by 
the friends. Reviews can hurt, and even if the out-
come is good, the wounds remain for a long time. 
Witness the embarrassing case of Rosalyn Yalow, 
who received the Nobel Prize for co-developing 
the radioimmunoassay: she displayed a rejection 
letter from the Journal of Clinical Investigation in 
her Nobel Lecture.3 Reviewing papers, like science 
itself, is a human activity, and nobody is implying 
that referees are saints. But let us see what actually 
was written about the 24 papers under scrutiny. 
Although space does not permit showing the 
full comments of the reviewers, I have selected 
emblematic phrases. These were often sent to the 
editors and not meant to be shown to the authors; 
thus they probably reﬂect the true feelings of the 
reviewers more accurately than do the comments 
sent to the authors.
These reviewer comments are classified into 
several categories. In each category, the  com-
ments are verbatim, with minor changes to hide 
the subject matter; those by ‘friendly’ reviewers are 
green, and those by ‘antagonistic’ reviewers are red. 
I hope you will see that, more often than not, the 
responses say the same things, but often at diﬀerent 
emotional temperatures. 
Are these comments fair? That the acceptance 
rate of papers with selected reviewers is similar 
to that of papers with unselected reviewers sug-
gests that the reviewers were always fair; or, that 
the Editorial Board made corrections for such 
reviewers if they were not. The most interesting 
observation to be made about these comments 
is that reviewing—being an aspect of human 
nature—is, alas, unpredictable.
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Not original 
Overall, the data presented are not original, are mostly descriptive and do not provide new 
insight into the effect of x on yyy in this rat model.
 
Some data analysis also needs to be reworked and there is a significant methodological 
problem. Nevertheless, on balance I think that the paper should be published, but only 
after revision.
More studies are needed 
Additional control experiments are required and the authors need to more carefully point 
out the novel aspects of their study in view of the published data.
 
An interesting though somewhat limited observation with implications for understanding 
renal inflammation.
No mechanism presented 
While the experiments have been conducted carefully, the data do not advance the field 
significantly.
 
This paper is somewhat similar in scope to many papers which claimed x involvement in 
yyy. I think the mechanism linking x to yyy is still ill-defined. Clearly, more compelling data 
is required.
In vivo studies needed 
The experiments are straightforward. However, the importance of this finding should 
be established in vivo by demonstrating that x expression in diabetic rats or mice is 
ameliorated by the administration of yyy and that this has some effect on the sclerosis 
observed in these animals.
 
The effect of x is quite interesting; however, the mechanism of these effects are not entirely 
clear. The authors must show how x regulates transcriptional control of yyy. Another major 
problem is how x protects renal injury in diabetic nephropathy in vivo. In vivo experiments 
are essential to get a definite conclusion.
Enemies stab you in the front 
First, the information is not novel. Second, the design of the study is faulty. Finally, the 
hypothesis suggested by the authors was not proved. This is another descriptive study of a 
well-known phenomenon of high mortality in x.
 
This is a well written straightforward study that should be of interest to clinicians; I did not 
find any major flaws or errors in data handling or analysis.
Friends stab you in the back 
This study is interesting and addresses a potentially important issue in renal 
pathophysiology. However, there are several issues that should be clarified to make the 
study more robust.
 
The paper, while original in addressing the role of x in yyy, lacks originality in providing any 
new information regarding x function in inflammatory disease. I am disappointed by the 
lack of attention paid by the authors regarding what the data mean.
Enemies cannot resist a gratuitous jab 
It is a logical extension of their previous work but again several important controls are not 
present. I like the fact that they admit that their previous paper had flaws as no one could 
reproduce their data.
 
The major finding of study is the protective effect of a new x analogue which induces 
protection from yyy. The delayed treatment data is very impressive such that it might be 
useful as a new treatment of yyy, yet the manuscript needs major revision.
Friends suspect hidden motives 
There are however several methodological and analytical flaws in the study (vide infra). 
Moreover, some findings remain unexplained. Altogether these limitations preclude 
publication.
 
The study is not adequately performed, because only samples from a previous trial were 
analyzed. Neither the choice of the study nor the used dialyzers are appropriate to prove 
an effect. A market-driven intention must be suspected.
Your enemies have read your papers 
The authors demonstrated previously that x was not present as such but as a conjugate. 
When learning this, we stopped publishing on x. The authors, however, continue to publish 
on it as if nothing had happened.
 
This is an excellent paper. With a little more explanation (as below) it should be a good 
contribution.
